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Abstract
Background: Worldwide, cancer in the esophagus ranks among the 10 most common cancers.
Alterations of retinoic acid receptors (e.g. RARα, β, γ, and RXRα, β, γ) expression is considered
to play an important role in development of squamous-cell carcinoma (SCC), which is the most
common esophageal cancer. Alcohol consumption and smoking, which can alter retinoic acid
receptor levels, have been identified as key risk factors in the development of carcinoma in the
aero-digestive tract. Therefore, the aim of the present study was to evaluate protein levels of
retinoic acid receptors (i.e. RARα, β, γ, and RXRβ) in esophageal SCC and surrounding normal
tissue of patients with untreated SCC and controls.
Methods:  All study participants completed a questionnaire concerning smoking and alcohol
drinking habits as well as anthropometrical parameters. Protein levels of RARα, β, γ, and RXRβ
were determined by Western Blot in normal esophageal tissue and tissue obtained from SCC of
21 patients with newly diagnosed esophageal SCC and normal esophageal tissue of 10 controls.
Results: Protein levels of RARγ were significantly lower by ~68% in SCC compared to normal
surrounding tissue in patients with SCC that smoked and/or consumed elevated amounts of
alcohol. Furthermore, RARα protein levels were significantly lower (~- 45%) in SCC in comparison
to normal esophageal mucosa in patients with elevated alcohol intake. When comparing protein
levels of retinoic acid receptors between normal tissue of patients with SCC and controls, RARγ
protein levels were found to be significantly higher (~2.7-fold) in normal esophageal tissue of SCC
patients than in esophageal tissue obtained from controls. No differences were found for RARα, β,
and RXRβ protein levels between normal esophageal tissue of patients and that of controls.
Conclusion: In conclusion, results of the present study suggest that alterations of retinoic acid
receptors protein may contribute in the development of SCC in esophagus and that in some
patients life style (e.g. smoking and alcohol consumption) may be a critical component in the
alteration of retinoic acid receptor levels in esophagus.
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Background
Worldwide esophageal cancer ranks among the ten most
common cancers [1] and the overall 5-year survival rate
for patients diagnosed with esophageal cancer is poor
(e.g. 3%–10%) [2]. Although, there is a rising entity of
adenocarcinoma [3], the majority of carcinoma of the
esophagus are squamous-cell carcinoma (SCC) [1]. Multi-
ple epidemiological studies indicate that alcohol and
tobacco may be important risk factors for the develop-
ment of carcinoma in the esophagus [1,4]. In a case-con-
trol study, Valsecchi et al. [5] showed that people who
smoked 40 or more years had almost 6-times the risk of
esophageal cancer development compared to non-smok-
ers. Those with a history of alcohol consumption of more
than two beers per day had 3-times the risk in comparison
to abstainers. Furthermore, the combination of both hab-
its was found to have a synergistic effect, increasing the
relative risk for developing cancer in the aero-digestive
tract up to 17.3-times over that of the non-smokers, non-
drinkers [6]. However, despite intense research [7], molec-
ular pathomechanisms involved in the development of
esophageal SCC are not fully understood so far contribut-
ing to the lack of successful pharmacological therapies.
Alterations of retinoid metabolism and retinoic acid
receptor (e.g. RARα, β, γ, and RXRα, β, γ)-mediated gene
transcription have been proposed to play an important
role in the pathogenesis of SCC [8-10]. It is well estab-
lished that RARs and RXRs are ligand-dependent tran-
scription factors with distinct expression patterns in early
and adult stages of development. Therefore, down-regula-
tion (e.g. loss or low expression of the specific nuclear
receptor) or "functional" down-regulation (e.g. lack of lig-
ands) of both retinoic acid receptor families could inter-
fere with the retinoid signal transduction and, over time,
might result in enhanced cell proliferation and malignant
transformation. An association between altered expres-
sion of nuclear retinoic acid receptors and the malignant
transformation of human cells has been demonstrated in
several studies [11-14]. Furthermore, a reduced expression
of RARγ found in head and neck SCC cell lines [15] seems
to depend on a sufficient Vitamin A supplementation
[16].
Since little is known about the abundance of RARs and
RXRs protein in esophageal SCC in humans, the major
focus of the present study was to determine protein levels
of RARα, β, γ, and RXRβ in normal, macroscopically unaf-
fected esophageal tissue and SCC of patients with
untreated SCC and controls. In addition, alcohol intake
and smoking habits of patients and controls were evalu-
ated and related to retinoic acid receptor levels.
Materials and methods
Subjects and tissue specimens
The study was approved by the Ethics Committee of the
Medical Clinic of the University of Cologne, Germany.
Informed consent was obtained from all subjects included
in the study. A total of 31 subjects, all of whom were
undergoing endoscopies for medical reasons, were
included in the study. Twenty-one patients had untreated
SCC of the esophagus, and ten SCC-free subjects served as
controls. Histopathological analysis of SCC was per-
formed by an experienced physician. Tumor staging was
based on a graded rating system and varied from G1 (well
differentiated) to G3 (poorly differentiated). In controls,
the presence or absence of SCC was confirmed macro-
scopically. All study participants completed a question-
naire concerning smoking and alcohol drinking habits as
well as anthropometrical parameters. Using standard
pinch forceps, two biopsies were obtained from macro-
scopically normal esophageal tissue and SCC of subjects
with carcinoma and from the mucosa of healthy controls.
Biopsies were placed immediately in liquid nitrogen and
stored at -80°C until analysis.
Immunoblot Analysis
Total protein was isolated using Trizol reagent (Invitro-
gen, Carlsbad, CA, USA). Using SDS-polyacrylamide gel
electrophoresis, 20–30 µg of total protein were separated
in a 9% polyacrylamide gel (PAGE). Protein was trans-
ferred to a nitrocellulose membrane (Amersham/ Phar-
macia, Freiburg, Germany). Membranes were blocked in
Tris-buffered saline (TBS) with 5% non-fat milk powder
with Tween 20 (TBST, 0.01% v/v Tween 20), rinsed in
TBST, and probed with primary antibodies dissolved in
TBS followed by an incubation with the secondary anti-
body. Primary antibodies against RARα, β, γ, and RXRβ
were obtained from Alexis (Dianova, Hamburg, Ger-
many), the secondary peroxidase-conjugated antibodies
were purchased from Boehringer (Mannheim, Germany).
Bands were visualized by enhanced chemiluminescence
using SuperSignal® West Dura (Pierce, KTM, Bad Godes-
berg, Germany). Blots were photographed (Camera LAS
1000, Fuji, USA) and immunoquantitation was accom-
plished by densitometric analysis using the software AIDA
(Raytest, Isotopenmessgeraete, Straubenhardt, Germany).
To achieve standardization and comparability of blots,
total protein derived from human liver was loaded on
each gel at three concentrations (50 µg, 25 µg, and 12.5
µg) and blottet with the samples. To ensure equal loading,
all blots were stained with Ponceau red; haptene signals
were normalized to β-actin using a commercially availa-
ble antibody (Sigma Chemical Co., Munich, Germany).
Statistical Analysis
Results are presented as mean ± standard error of the
mean (SEM), unless otherwise stated. Wilcoxon t test wasJournal of Carcinogenesis 2005, 4:20 http://www.carcinogenesis.com/content/4/1/20
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used to test for significance of differences in expression
levels measured in both normal and malignant tissue of
patients with SCC. Fisher's exact test was used for compar-
ison of lifestyle data. Statistical comparison of values orig-
inating from separate groups was performed with the
Mann-Whitney U-test. P < 0.05 was considered to repre-
sent a significant difference.
Results
Subject age ranged from 38–71 years and most were of
normal weight (Table 1). Smoking habits did not differ
between patients and controls. However, significantly
more patients with SCC reported to consume "elevated"
amounts of alcohol (more than 30 g of alcohol/d or more
4-times a week more than 1 drink) in comparison to con-
trols (Table 1). Tumor grading ranged form G1 to G3 with
the majority being G2 (Table 2).
Retinoic acid receptor protein levels in patients with 
untreated esophageal SCC
Figures 1 and 2 summarize the results of protein measure-
ments performed in biopsy specimens obtained from SCC
and neighboring normal esophageal tissue of patients
with untreated esophageal SCC. Western Blot analyses
demonstrated that RARα, β, γ, and RXRβ were present as a
major immunoreactive band representing the 55 kDa
monomer in all tissue samples tested (see Figure 1). Pro-
tein levels of RARγ were found to be significantly lower in
specimens obtained from SCC in comparison to sur-
rounding normal tissue. Specifically, RARγ protein levels
were ~47% lower in SCC when compared with those of
normal, unaffected esophageal tissue (p = 0.040). In con-
trast, no significant differences were found when compar-
ing protein levels of RARα, RARβ, and RXRβ between
macroscopically normal, unaffected esophageal tissue
and SCC.
To investigate whether smoking and alcohol consump-
tion influences protein levels of esophageal retinoic acid
receptors of patients with SCC were grouped by smoking
habits (e.g. non-smoker or smoker) regardless of their
alcohol consumption. In smokers, RARγ protein levels
were found to be significantly lower (~68%, p = 0.010) in
SCC in comparison to unaffected esophageal tissue in
smoking patients (n = 10). Interestingly, a similar differ-
ence was not found in patients who were non-smokers (n
= 11, data not shown). Similar, patients were than sub-
grouped by alcohol intake regardless of their smoking
habits into patients who (a) reported to consume no alco-
hol (= "none"), (b) who reported to be "moderate" alco-
hol consumers not exceeding alcohol intake more than
once a week, or (c) who stated to consume alcohol more
than 4-times a week or more than 30 g raw ethanol/ d (see
also Table 2). Since only 4 patients reported to be abstain-
ers and since two patients in this group stated to have
given up heavy alcohol consumption several years ago,
this group was excluded from the statistical analysis.
Results are summarized in Figure 3. When comparing pro-
tein levels of retinoic acid receptors between SCC and
unaffected tissue obtained from patients who reported to
consume "elevated" amounts of alcohol (n = 9), RARγ
protein levels were again found to be significantly lower
in SCC in comparison to neighboring normal tissue
(~40%, p = 0.038). Furthermore, in this subgroup of
patients, in biopsies obtained from SCC protein levels of
RARα were ~55% lower in comparison to normal tissue
(p = 0.049). Again, similar to non-smokers, in patients
who were moderate consumers of alcohol (n = 8), neither
protein levels of RARα nor RARγ were found to differ
between tissue obtained from SCC and normal esopha-
geal tissue (data not shown). Next, receptor protein levels
were compared between SCC and normal tissue of
Table 2: Tumor staging of patients with SCC.
Tumor stage n
G1 2
G1-2 2
G2 8
G2-3 4
G3 5
G1 = well differentiated
G2 = moderately differentiated
G3 = poorly differentiated
Table 1: Characteristics of patients with untreated esophageal 
SCC and controls.
Parameter Patients Controls p-values
n2 1 1 0
Age 56.7 ± 1.9 51.1 ± 3.5 0.118
Sex (female/male) 7/14 5/5 0.425
BMI 23.8 ± 1.4 25.1 ± 0.6 0.370
Cigarette usage (yes/no) 10/11 3/7 0.242
Alcohol consumption*)
none 4**) 2 0.012
moderate 8 8
elevated 9 0
All data expressed as mean ± SEM. (BMI = body mass index, p < 0.05 
statistically significant) *) none = study subject reported to never drink 
alcohol; moderate = study subject reported to drink alcohol 
sometimes (not more than once a week); elevated = study subject 
reported to consume alcohol more than 4-times a week (more than 
one drink) or more than 30 g ethanol/d on the average **) two patients 
had been former heavy alcohol abusers but reported to have given up 
alcohol consumption several years agoJournal of Carcinogenesis 2005, 4:20 http://www.carcinogenesis.com/content/4/1/20
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patients who consumed elevated amounts of alcohol and
smoked (n = 6). Interestingly, only levels of RARγ were
found to be significantly lower by ~68% in esophageal
SCC in comparison to normal esophageal tissue (p =
0.046). As to be expected, in patients, who had a "moder-
ate" alcohol consumption and were non-smokers, no dif-
ferences were found in protein levels of RARs or RXRβ.
Retinoic acid receptor protein levels in normal tissue of 
patients with esophageal SCC and controls
Since it has been suggested by the results of others (19)
that basal levels of retinoic acid receptor mRNA expres-
sion in normal unaffected tissue might differ between
patients with SCC and controls, protein levels of RARα, β,
γ, and RXRβ were determined in esophageal tissue
obtained form controls and compared with protein levels
measured in normal esophageal tissue obtained from
patients with esophageal SCC. Representative Western
blots are depicted in Figure 1 A and quantitative analysis
of blots is summarized in Figure 4. Analysis revealed a sig-
nificantly higher protein concentration of RARγ in normal
unaffected tissue of patients with esophageal SCC in com-
parison to controls. Specifically, protein levels were found
to be ~2.7-fold higher in normal tissue of patients when
compared with controls (p = 0.048). No significant differ-
ences were found when comparing protein levels of
RARα, γ, and RXRβ measured in normal, macroscopically
unaffected tissue specimens of patients and controls.
Discussion
Alterations of RARγ and RARα protein levels in patients 
with esophageal SCC are depending on life style
In the present study, the hypothesis was tested that altered
protein levels of retinoic acid receptors might be involved
in the development of esophageal SCC in humans.
Indeed, protein levels of RARγ were found to be signifi-
cantly lower in SCC relative to normal tissue in patients
who smoked and consumed alcohol. A similar difference
was found for RARα in SCC patients who reported to con-
sume "elevated" amounts of alcohol. However, dimin-
ished levels of RARγ and RARα were only found in these
sub-populations of patients with SCC in the esophagus,
suggesting that underlying mechanism leading to the
development of SCC may vary depending on life style of
patients. Several groups have previously determined
mRNA expression of RARs and RXRs in normal esopha-
geal tissue and SCC. Zhang et al. [17] and Qiu et al. [18],
who measured mRNA levels of RARs and RXRs found a
striking reduction of the expression of RARβ but not of
RARγ in malignant esophageal tissue in comparison to
normal tissue. Furthermore, in in situ studies a reduced
mRNA expression of RARα was found in esophageal SCC
compared with normal tissue [11]. However, in these
Protein levels of RARα, β, γ, and RXRβ in patients with  esophageal SCC Figure 2
Protein levels of RARα, β, γ, and RXRβ in patients 
with esophageal SCC. Quantitative analysis of Western 
blots performed in normal tissue of patients with SCC and 
tissue obtained form SCC. Protein levels of β-actin were 
determined as loading control. Data are means ± SEM. *p < 
0.05
RARα, β, γ, and RXRβ protein in human esophagus Figure 1
RARα, β, γ, and RXRβ protein in human esophagus. 
Representative Western blot of RARα, β, γ, and RXRβ pro-
tein in normal esophagus of controls and normal, unaffected 
esophageal tissue of patients with untreated esophageal SCC 
and SCC. Protein levels of β-actin were determined as load-
ing control.Journal of Carcinogenesis 2005, 4:20 http://www.carcinogenesis.com/content/4/1/20
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studies, no information was given on life style parameters
such as smoking and alcohol intake and patients were not
sub-grouped accordingly and only mRNA expression lev-
els of RARs and RXRs were evaluated.
Due to the retrospective character of the present study it
can only be speculated whether the association of ciga-
rette smoking and reduced protein levels of RARγ in SCC
is a cause – and effect relationship or not. However, the
action of tobacco carcinogens are believed to be mediated
through covalent binding to DNA, RNA, or protein, form-
ing DNA, RNA, and protein adducts [19]. Furthermore,
results of in vitro and  in vivo studies [20] suggest that
tobacco carcinogens (e.g. benzo(a)pyrene diol epoxide)
might lead to DNA methylation of RAR genes subse-
quently resulting in an inhibition of the expression of
RARs rather than mediating their action through direct
mutations.
Several mechanism have been proposed to explain how
alcohol ingestion may interfere with retinoid metabolism.
First, it has been shown that alcohol may act as a compet-
itive inhibitor of oxidation of retinal to retinoic acid in
several organs (e.g. colon and esophagus) [21-23]. Sec-
ondly, Liu et al. [24] reported an enhanced catabolism of
retinoids into polar metabolites in the liver of ethanol-fed
rats compared to pair-fed animals. This was found to be
inhibited in vitro and in vivo by chlormethiazol, an inhib-
Protein levels of RARα, β, γ, and RXRβ in smoking and alco- hol consuming patients with esophageal SCC Figure 3
Protein levels of RARα, β, γ, and RXRβ in smoking 
and alcohol consuming patients with esophageal 
SCC. Quantitative analysis of RARα, β, γ, and RXRβ protein 
levels in normal unaffected esophageal tissue und SCC of (A) 
smoking SCC patients, (B) patients with "elevated" alcohol 
consumption, and (C) smoking SCC patients with "elevated" 
alcohol intake. Protein levels of β-actin were determined as 
loading control. Data are means ± SEM. *p < 0.05 (Normal 
tissue = macroscopically unaffected tissue, SCC = squamous-
cell carcinoma)
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RARα, β, γ, and RXRβ protein levels in normal esophageal  tissue of patients with SCC and controls Figure 4
RARα, β, γ, and RXRβ protein levels in normal 
esophageal tissue of patients with SCC and controls. 
Quantitative analysis of RARα, β, γ, and RXRβ protein levels 
as determined by Western blot. Protein levels of β-actin 
were determined as loading control. Data are means ± SEM. 
*p < 0.05Journal of Carcinogenesis 2005, 4:20 http://www.carcinogenesis.com/content/4/1/20
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itor of cytochrome P4502E1 (CYP2E1). A significant
induction of CYP2E1 was found after one week of chronic
alcohol ingestion in human subjects [25]. Therefore, the
induction of CYP2E1 (and/or other cytochrome P450 iso-
forms) activity during chronic alcohol intake could add to
a reduced bioavailability of retinoic acid subsequently
resulting in changes in the expression of RARs and RXRs.
Thirdly, it has been shown that levels of cellular retinoic
acid binding protein (CRABP) can be reduced in esopha-
geal carcinoma (e.g. adenocarcinoma and SCC) [26]. This,
in turn, may lead to alterations of receptor expression and
turnover. However, whether these mechanisms play a role
in the present study remains to be determined.
RARγ protein levels are elevated in normal esophageal 
mucosa of patients with SCC
Untill now, information on protein levels of retinoic acid
receptors in normal unaffected esophageal tissue has been
limited. Recently, in a study determining the role of RXR
mRNA in Barett's esophagus mRNA levels of RXRβ were
found to be higher in non-malignant tissue in patients
with adenoma than in healthy controls [27]. In the
present study, protein levels of RARγ were found to be sig-
nificantly higher in normal esophageal tissue of patients
with esophageal SCC in comparison to controls. It may be
that the differences between the results of others [27] and
the present study are due to differences of patients (e.g.
patients with SCC vs. patients with Barrett esophagus) or
differences of detection sensitivity (mRNA expression vs.
protein).
Conclusion
The results of the present study provide further evidence
that a diminished abundance of retinoid acid receptors in
esophagus is associated with the development of esopha-
geal SCC in humans. Furthermore, in some patients life
style (e.g. smoking and alcohol consumption) may con-
tribute to the alteration of retinoic acid receptor levels in
esophagus. Further studies will be required to elucidate
this interaction of alcohol consumption, smoking, and
retinoic acid receptor signaling with the development of
SCC in the esophagus.
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